Abstract | RATIONALE: The comparative efficacy and cost-effectiveness of constraint-induced and multi-modality aphasia therapy in chronic stroke are unknown. AIMS AND HYPOTHESES: In the COMPARE trial, we aim to determine whether Multi-Modal Aphasia Treatment (M-MAT) and Constraint-Induced Aphasia Therapy Plus (CIAT-Plus) are superior to usual care (UC) for chronic post- stroke aphasia. Primary hypothesis: CIAT-Plus and M-MAT will reduce aphasia severity (Western Aphasia Battery-Revised Aphasia Quotient (WAB-R-AQ)) compared with UC: CIAT-Plus superior for moderate aphasia; M-MAT superior for mild and severe aphasia. SAMPLE SIZE ESTIMATES: A total of 216 participants (72 per arm) will provide 90% power to detect a 5-point difference on the WAB-R-AQ between CIAT-Plus or M-MAT and UC at α = 0.05. METHODS AND DESIGN: Prospective, randomized, parallel group, open-label, assessor blinded trial. Participants: Stroke >6 months; aphasia severity categorized using WAB-R-AQ. Computer-generated blocked and stratified randomization by aphasia severity (mild, moderate, and severe), to 3 arms: CIAT-Plus, M-MAT (both 30 h therapy over two weeks); UC (self-reported usual community care). STUDY OUTCOMES: WAB-R-AQ immediately post-intervention. Secondary outcomes: WAB-R-AQ at 12-week follow-up; naming scores, discourse measures, Communicative Effectiveness Index, Scenario Test, and Stroke and Aphasia Quality of Life Scale-39 g immediately and at 12 weeks post-intervention; incremental cost-effectiveness ratios compared with UC at 12 weeks. DISCUSSION: This trial will determine whether CIAT-Plus and M-MAT are superior and more cost-effective than UC in chronic aphasia. Participant subgroups with the greatest response to CIAT-Plus and M-MAT will be described.
|
Authors | Miranda L Rose, David Copland, Lyndsey Nickels, Leanne Togher, Marcus Meinzer, Tapan Rai, Dominique A Cadilhac, Joosup Kim, Abby Foster, Marcella Carragher, Melanie Hurley, Erin Godecke |
Journal | International journal of stroke : official journal of the International Stroke Society
(Int J Stroke)
Vol. 14
Issue 9
Pg. 972-976
(12 2019)
ISSN: 1747-4949 [Electronic] United States |
PMID | 31496440
(Publication Type: Clinical Trial Protocol, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Humans
- Aphasia
(etiology, rehabilitation)
- Combined Modality Therapy
- Cost-Benefit Analysis
- Severity of Illness Index
- Single-Blind Method
- Stroke
(complications)
- Stroke Rehabilitation
(economics, methods)
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Prospective Studies
|